The overnight selloff in US technology stocks is likely to spill over into Indian IT shares, putting pressure on the broader market and limiting
Author: techrossm
Stock market today: Nasdaq gets hit hardest as techs sink; Palantir climbs after earnings (live coverage)
Stock Market Today: Small caps join the S&P 500 and Dow in losses. Nvidia falls below this level.
Stock Market Today LIVE: Gift Nifty signals a flat start for Nifty 50, Sensex today
Asian markets traded mixed, while the stock market ended lower overnight after a sell-off in technology stocks. Sentiment in the domestic market remains upbeat
This Once-Sleepy Consumer Staples Stock Is Beating the S&P 500 by 8-to-1 in 2026: Should You Buy?
However, notice I said “decent,” rather than great when referring to Colgate-Palmolive’s stock performance. The stock significantly underperformed the S&P 500 ‘s 539% total
Stock Market LIVE Updates: GIFT Nifty indicates a weak start; US, Asian markets fall
Wall Street ended sharply lower on Tuesday as investors worried about AI creating more competition for software makers, keeping them on edge ahead of
Nvidia will consider investing in OpenAI IPO, Huang tells CNBC
Feb 3 (Reuters) – Nvidia CEO Jensen Huang told CNBC in an interview on Tuesday that the company would consider investing in OpenAI’s next
Dow Jones And U.S. Index Outlook: Major Rotation Flows And Drops
Let’s dive into today’s session charts and key trading levels for the major US indices: the Dow Jones, Nasdaq, and S&P 500, as profit-taking
Finance Leaders Weigh In on Trump, the Fed, Investing and AI Risk
WSJ Invest Live event features Citadel CEO Ken Griffin, Trian CEO Nelson Peltz and more.
Stock Market Today, Feb. 3: Rocket Companies Rallies on Signs of Mortgage Demand Recovery
Rocket Companies advanced after its CEO said mortgage loan production has reached a four-year high, as the market revisits the outlook for housing demand.
Stock Market Today, Feb. 3: Novo Nordisk Slides as Pricing Pressure Clouds Obesity-Drug Outlook
Novo Nordisk dropped after management forecasts weaker 2026 growth, shifting attention from recent results to pricing pressure and rising competition in obesity treatments.